278 related articles for article (PubMed ID: 30693974)
21. Defining the conformational states that enable transglutaminase 2 to promote cancer cell survival versus cell death.
Aplin C; Zielinski KA; Pabit S; Ogunribido D; Katt WP; Pollack L; Cerione RA; Milano SK
bioRxiv; 2024 Feb; ():. PubMed ID: 38370687
[TBL] [Abstract][Full Text] [Related]
22. The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression.
Tabolacci C; De Martino A; Mischiati C; Feriotto G; Beninati S
Med Sci (Basel); 2019 Jan; 7(2):. PubMed ID: 30691081
[TBL] [Abstract][Full Text] [Related]
23. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
Algarni AS; Hargreaves AJ; Dickenson JM
Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
[TBL] [Abstract][Full Text] [Related]
24. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
25. Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?
Kumar S; Mehta K
Amino Acids; 2013 Jan; 44(1):81-8. PubMed ID: 22083892
[TBL] [Abstract][Full Text] [Related]
26. Implications of tissue transglutaminase expression in malignant melanoma.
Fok JY; Ekmekcioglu S; Mehta K
Mol Cancer Ther; 2006 Jun; 5(6):1493-503. PubMed ID: 16818508
[TBL] [Abstract][Full Text] [Related]
27. Transglutaminase 2 in cancer.
Huang L; Xu AM; Liu W
Am J Cancer Res; 2015; 5(9):2756-76. PubMed ID: 26609482
[TBL] [Abstract][Full Text] [Related]
28. Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.
Muma NA
Med One; 2018; 3(6):. PubMed ID: 30701197
[TBL] [Abstract][Full Text] [Related]
29. Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2.
Biri B; Kiss B; Király R; Schlosser G; Láng O; Kőhidai L; Fésüs L; Nyitray L
Biochem J; 2016 Jan; 473(1):31-42. PubMed ID: 26487698
[TBL] [Abstract][Full Text] [Related]
30. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
[TBL] [Abstract][Full Text] [Related]
31. The Biological and Biomechanical Role of Transglutaminase-2 in the Tumour Microenvironment.
Tempest R; Guarnerio S; Maani R; Cooper J; Peake N
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34205140
[TBL] [Abstract][Full Text] [Related]
32. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
Quinn BR; Yunes-Medina L; Johnson GVW
J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
[TBL] [Abstract][Full Text] [Related]
33. Tissue transglutaminase-interleukin-6 axis facilitates peritoneal tumor spreading and metastasis of human ovarian cancer cells.
Oh K; Moon HG; Lee DS; Yoo YB
Lab Anim Res; 2015 Dec; 31(4):188-97. PubMed ID: 26755922
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of tissue transglutaminase 2 in colon carcinoma.
Fernández-Aceñero MJ; Torres S; Garcia-Palmero I; Díaz Del Arco C; Casal JI
Virchows Arch; 2016 Dec; 469(6):611-619. PubMed ID: 27620315
[TBL] [Abstract][Full Text] [Related]
35. New insights into the functions and localization of nuclear transglutaminase 2.
Kuo TF; Tatsukawa H; Kojima S
FEBS J; 2011 Dec; 278(24):4756-67. PubMed ID: 22051117
[TBL] [Abstract][Full Text] [Related]
36. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Transglutaminase 2 activity increases cisplatin cytotoxicity in a model of human hepatocarcinoma chemotherapy.
Meshram DD; Pike CVS; Coussons PJ
Eur J Pharmacol; 2017 Nov; 815():332-342. PubMed ID: 28943101
[TBL] [Abstract][Full Text] [Related]
38. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
[TBL] [Abstract][Full Text] [Related]
39. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
Mangala LS; Fok JY; Zorrilla-Calancha IR; Verma A; Mehta K
Oncogene; 2007 Apr; 26(17):2459-70. PubMed ID: 17043648
[TBL] [Abstract][Full Text] [Related]
40. Tissue transglutaminase: from biological glue to cell survival cues.
Mehta K; Fok JY; Mangala LS
Front Biosci; 2006 Jan; 11():173-85. PubMed ID: 16146723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
